Meta is assembling an elite new AI lab for its recommendations division
Business Insider· 2026-04-01 09:00
Core Insights - Meta is establishing a team of elite AI researchers, named MRS Research, to enhance algorithms that drive user engagement on Facebook and Instagram [1][3] - The formation of MRS Research is part of a reorganization within Meta to consolidate relevant teams and focus on long-term AI research goals [2][3] - The initiative aims to advance Meta's recommendation engine and improve ad performance through AI technology [3][7] Team Composition - MRS Research has attracted talent from major tech companies, including TikTok and Amazon, with notable hires such as Yang Song and Lihong Li [4][5] - The overall MRS division has also added researchers from OpenAI and Google, indicating a strong focus on acquiring top AI talent [5][6] Strategic Direction - Meta's aggressive AI talent acquisition campaign began in summer 2025, with the establishment of Meta Superintelligence Labs (MSL) [6] - The company is rebranding employees in other divisions as "AI builders" and is actively exploring new AI technologies to enhance its applications [7]
Correction: Form 8.3 LondonMetric Property Plc & Schroder REIT Limited
Globenewswire· 2026-04-01 08:59
Group 1 - Rathbones Group Plc disclosed interests in relevant securities representing 1% or more under Rule 8.3 of the Takeover Code [1][17] - The disclosure relates to a consortium comprising LondonMetric Property plc and Schroder Real Estate Investment Trust Limited [1][17] - The date of the position held was 31/03/2026 [1][17] Group 2 - Rathbones Group Plc holds 85,428,649 shares in LondonMetric Property plc, representing 3.64% of the relevant securities [3][19] - The company also holds 19,883,983 shares in Schroder Real Estate Investment Trust, representing 4.06% of the relevant securities [4][19] Group 3 - Recent dealings include multiple sales and purchases of LondonMetric 10p Ordinary Shares, with sales totaling 28,967 shares at 179.0799p and purchases totaling 41,000 shares at 178.29p [8][23][24] - The total number of shares sold and purchased indicates active trading in LondonMetric shares [8][23][24]
Nike shares sink as weak outlook and China slump hit recovery
Invezz· 2026-04-01 08:56
Core Viewpoint - Nike's shares experienced a significant decline in after-hours trading due to a warning about a decrease in current-quarter revenue, highlighting ongoing challenges in the crucial China market and an inconsistent recovery [1] Group 1: Revenue Outlook - The company anticipates a decline in revenue for the current quarter, indicating potential financial difficulties ahead [1] - This forecast reflects the ongoing struggles in the Chinese market, which is a key area for Nike's sales [1] Group 2: Market Challenges - Persistent challenges in the China market are affecting Nike's overall performance, suggesting that the company may need to reassess its strategies in this region [1] - The uneven turnaround in business operations indicates that recovery efforts may not be yielding the expected results [1]
Strength Seen in Dianthus Therapeutics, Inc. (DNTH): Can Its 5.6% Jump Turn into More Strength?
ZACKS· 2026-04-01 08:55
Group 1 - Dianthus Therapeutics, Inc. (DNTH) shares increased by 5.6% to close at $83.92, with a significant trading volume compared to normal sessions, and a total gain of 43.8% over the past four weeks [1][2] - The rise in share price is linked to positive investor sentiment regarding the company's pipeline, particularly following an early "GO" decision in the late-stage CAPTIVATE study for claseprubart, aimed at treating chronic inflammatory demyelinating polyneuropathy (CIDP) [2] - The stock received further support after the FDA approved several proposed changes to the clinical development of claseprubart, affecting all ongoing and future studies [3] Group 2 - The company is projected to report a quarterly loss of $1.17 per share, reflecting a year-over-year decline of 42.7%, with expected revenues of $0.55 million, down 53% from the previous year [4] - The consensus EPS estimate for the quarter has been revised down by 27.6% over the last 30 days, indicating a negative trend in earnings estimate revisions, which typically does not lead to price appreciation [5] - Dianthus Therapeutics, Inc. holds a Zacks Rank of 3 (Hold), indicating a neutral outlook, while another company in the same industry, Foghorn Therapeutics Inc. (FHTX), has also experienced a decline in stock performance [6]
U.S. Futures And World Markets Rise, Buoyed By Hopes Of Quick End To Iran War
Forbes· 2026-04-01 08:55
Core Viewpoint - U.S. stock futures and global markets are experiencing a surge due to optimism surrounding a potential resolution to the Iran war, following President Trump's announcement of a planned withdrawal of American forces within two to three weeks [1][2]. Market Performance - In early trading, the Dow Futures index increased by 0.43% to 46,780 points, while the S&P 500 Futures rose by 0.5% to 6,604 points, continuing a rally that saw both indexes rise by 2.5% on Tuesday [1]. - The tech-centric Nasdaq futures climbed to 24,092.50 points, reflecting a 0.75% increase from Tuesday's close [2]. - Asian markets showed significant gains, with Japan's Nikkei 225 surging by 5.24% and South Korea's KOSPI jumping by 8.44%. Other indices, such as Hong Kong's Hang Seng and India's Sensex, rose by 1.91% and 2.27%, respectively [2]. - European markets also experienced sharp increases, with the pan-European STOXX Europe 50 rising by 2% and the London Stock Exchange's FTSE 100 increasing by 1.3% [3]. Oil Prices - The optimism regarding a swift resolution to the Iran conflict has led to a notable impact on oil prices, with the global benchmark Brent Crude Index briefly falling below $100 per barrel. As of the report, Brent Crude Futures contracts for June were priced at $101.67 per barrel, while the now-expired May contracts had risen to nearly $120 per barrel due to ongoing tensions in the Persian Gulf [4].
2025 Sustainability Statement: Tarkett delivers concrete climate progress, cutting value-chain emissions by 27% in line with its 2030 goals
Globenewswire· 2026-04-01 08:52
Core Insights - Tarkett has achieved a 27% reduction in greenhouse gas emissions across its entire value chain, aligning with its 2030 sustainability goals [2] - The company has doubled the average proportion of recycled materials in its products from 10% in 2018 to 20% in 2025, with a target of reaching 30% by 2030 [2][4] - Tarkett's net sales reached €3.3 billion in 2025, with a workforce of 12,000 employees and operations in over 100 countries [4] Sustainability Progress - Tarkett's sustainability roadmap has seen significant advancements, including the deployment of its ReStart® take-back and recycling program in 29 countries [4] - The company has collected 129,000 tons of end-of-life flooring over the past 16 years, equivalent to 12 Eiffel Towers [4] - In 2025, Tarkett recovered 86,000 m² of end-of-life vinyl flooring from IKEA stores, avoiding 1,000 tons of greenhouse gas emissions [4] Energy and Resource Management - 43% of Tarkett's energy consumption comes from renewable sources, with 16 plants purchasing 100% renewable electricity [4] - The use of wood dust as biomass for energy production at six plants has led to a reduction of 12.4ktCO₂e, equivalent to removing 6,500 passenger cars from the road for a year [4] Circular Economy Initiatives - Tarkett has developed a reuse offer for second-hand carpet tiles, collecting 9,000 m² of old carpets in 2025, with 2,000 m² sent for recycling and 7,000 m² for reuse [4] - The company's infill regeneration facilities in Pennsylvania and Oregon collected and recovered 14,100 tons of infill for reuse in new projects in 2025, marking a 21% increase from 2024 [4] Diversity and Inclusion - The share of women in management positions at Tarkett has reached 29%, progressing towards a global goal of 33% by 2030 [4]
Billionaire Ken Griffin Buys 2 AI Stocks Chasing a $1 Trillion Market Opportunity in Robotaxis (Hint: Not Tesla)
The Motley Fool· 2026-04-01 08:48
Market Opportunity - Light-duty vehicles in the U.S. travel over 3 trillion miles annually, with ride-sharing services charging $1 to $2 per mile, indicating a potential trillion-dollar market for robotaxis in the U.S. alone [1] Nvidia - Ken Griffin's hedge fund has significant holdings in Nvidia, which is the industry standard for AI workload acceleration through its GPUs, essential for developing robotaxis [2][4] - Nvidia's software ecosystem, including code libraries and pretrained models, facilitates the development of autonomous driving systems [5] - The integration of Nvidia's tools, such as Omniverse for simulation and Cosmos for generating synthetic data, enhances the training of AI models for autonomous vehicles [6][8] - Nvidia's CFO stated that robotaxis could generate hundreds of billions in revenue over the next decade, with every major OEM utilizing Nvidia technology [8][9] - Wall Street estimates Nvidia's earnings will grow at 38% annually over the next three years, making its current valuation of 35 times earnings appear attractive [9] Amazon - Amazon's second-largest holding is Zoox, which operates purpose-built robotaxis without traditional driving controls, currently providing rides in Las Vegas and San Francisco [10][11] - Zoox is testing robotaxis in Austin and plans to expand its service area, having applied for a commercial ride-sharing service with up to 2,500 vehicles [12] - Morgan Stanley projects Zoox will account for 12% of autonomous rides annually by 2032, positioning it behind major competitors like Waymo, Tesla, and Uber [13] - Amazon's core businesses, including e-commerce and cloud computing, are expected to see earnings growth of 19% annually over the next three years, with a current valuation of 29 times earnings being attractive [14]
Novo Nordisk shares rise after Wegovy recommended by Britain's drug price regulator
CNBC· 2026-04-01 08:47
Core Insights - Novo Nordisk's stock rose by as much as 4% following a recommendation from England's drug price regulator to use its drug Wegovy for preventing heart attacks and strokes [1] - The recommendation from the National Institute for Health and Care Excellence (NICE) will significantly increase access to Wegovy through the National Health Service (NHS) in England [2] - NICE has recommended semaglutide, the active ingredient in Wegovy, for adults with a BMI of at least 27 who have a history of heart attack, stroke, or serious circulation issues [3] Group 1 - Novo Nordisk's shares were observed to be up 2% in morning trading, reflecting a positive market response [3] - The broader market, represented by the pan-European blue-chip index Stoxx 600, also saw an increase of 2.1% [3]
Baidu robotaxis reportedly halted mid-traffic causing crashes in Wuhan, China
CNBC· 2026-04-01 08:45
Core Insights - Baidu's Apollo Go robotaxis experienced a malfunction, leading to vehicles stalling mid-traffic in Wuhan, causing highway collisions [1][2] - The Wuhan local traffic police confirmed the incident, attributing it to system malfunctions and stating that passengers were safely evacuated [2][3] - Apollo Go operates the largest robotaxi deployment in China, with over 1,000 vehicles functioning without human drivers in Wuhan [3] Company Developments - Baidu has significantly invested in its driverless ride-hailing unit, paralleling Alphabet's investment in its Waymo robotaxi service [4] - Apollo Go is currently providing commercial driverless ride-hailing services in major Chinese cities, including Wuhan and suburban Beijing [6] - As of the fourth quarter of 2025, Apollo Go's driverless vehicles are deployed or being tested in 26 international cities [6] Competitive Landscape - Apollo Go faces competition from other Chinese autonomous vehicle manufacturers such as WeRide and Pony.AI [5] - Tesla is also developing driverless vehicles but has not yet launched a commercial robotaxi service outside of a limited pilot in Austin, Texas [5]
Brent oil futures fall as low as $98 ahead of Trump's address on Iran war
MarketWatch· 2026-04-01 08:44
Core Viewpoint - Both President Donald Trump and Iranian President Masoud Pezeshkian indicated that the ongoing conflict may reach a resolution soon [1] Group 1 - The statements from both leaders suggest a potential shift in diplomatic relations [1] - The optimism expressed by the leaders could impact market sentiments and investor confidence in the region [1]